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The development of therapeutic strategies to combat
immune-associated diseases requires the molecular
mechanisms of human Th17 cell differentiation to be
fully identified and understood. To investigate tran-
scriptional control of Th17 cell differentiation, we
used primary human CD4+ T cells in small interfering
RNA (siRNA)-mediated gene silencing and chromatin
immunoprecipitation followed by massive parallel
sequencing (ChIP-seq) to identify both the early
direct and indirect targets of STAT3. The integrated
dataset presented in this study confirms that
STAT3 is critical for transcriptional regulation of early
human Th17 cell differentiation. Additionally, we
found that a number of SNPs from loci associated
with immune-mediated disorders were located at
sites where STAT3 binds to induce Th17 cell specifi-
cation. Importantly, introduction of such SNPs alters
STAT3 binding in DNA affinity precipitation assays.
Overall, our study provides important insights for
modulating Th17-mediated pathogenic immune re-
sponses in humans.
INTRODUCTION
Th17 cell differentiation is selectively induced by a combination
of the cytokines transforming growth factor b-1 (TGFb-1), inter-
leukin 6 (IL-6), and/or IL1-b (Acosta-Rodriguez et al., 2007;
O’Garra et al., 2008; Veldhoen et al., 2006). Stimulation by IL-6
leads to the activation of the signal transducer and activator of
transcription 3 (STAT3). Upon phosphorylation, STAT3 regulates
the transcription of its target genes, including the transcription1888 Cell Reports 19, 1888–1901, May 30, 2017 ª 2017
This is an open access article under the CC BY-NC-ND license (http://factors RORgt and RORa and the signature cytokines IL-17A,
IL-17F, IL-21, and IL-23 (Chen and O’Shea, 2008; Durant et al.,
2010; Murphy and Stockinger, 2010; O’Garra et al., 2008).
Th17 cell differentiation is significantly impaired in STAT3-defi-
cient T cells, whereas overexpression of active STAT3 results in
increased production of IL-17 (Durant et al., 2010; Laurence
et al., 2007; Mathur et al., 2007; Yang et al., 2007). In spite of
its importance, current understanding on STAT3 and its role in
Th17 cell differentiation is primarily based on studies done in
mouse cells, whereas very little is known from human studies.
The importance of STAT3 in human diseases is highlighted by
reports indicating that mutations directly influencing the DNA-
binding and SRC homology 2 domains of STAT3 cause a com-
plex disease, hyper-immunoglobulin E (hyper-IgE) syndrome
(also called Job’s syndrome) (Holland et al., 2007; Ma et al.,
2008; Milner et al., 2008). On the other hand, recent studies
show that gain-of-function mutations of STAT3 contribute to
multi-organ autoimmunity, autoimmune cytopenia, lymphopro-
liferation, and immune deficiency (Flanagan et al., 2014; Haapa-
niemi et al., 2015; Milner et al., 2015). Identification of down-
stream targets of STAT3 in human cells is of particular interest,
because STAT3 is a key upstream mediator of cytokine-recep-
tor-induced initiation of Th17 cell differentiation. Therefore,
genes regulated by STAT3 are responsible for eliciting the early
stages of the Th17 cell differentiation program.
In this study, a combination of genome-wide analysis
methods and computational data integration enabled us to
identify direct and indirect STAT3 targets during the initiation
of human Th17 cell differentiation. Within the STAT3-binding
sites and STAT3-regulated genes, we detected a number of
SNPs from loci that have been associated with immune disor-
ders, including type 1 diabetes (T1D), Crohn’s disease (CD),
and psoriasis (PS). Introduction of such SNPs can influence
transcriptional regulation and thereby cellular differentiation
and immunopathogenesis.creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Downregulation of STAT3 Influences Human Th17 Cell Differentiation
(A) Western blot analysis showing the expression level of STAT3 and BATF proteins after introduction of three different individual STAT3 siRNAs (si1, si2, and si3)
into cord blood CD4+ T cells and culturing the cells for 24 hr in Th0 or Th17 cell polarizing conditions. Non-targeting control-siRNA (Scr) was used as a control and
b-actin as a protein loading control. Representative results from three independent experiments are shown.
(B) IL-17A secretion after 72 hr of culture. The cytokine was detected directly from the culture supernatant with Luminex fluorescent-coded beads. The values
were first normalized with the number of living cells determined based on forward (FSC) and side scattering (SSC) detected with a flow cytometer. IL-17A
secretion was compared between cells transfected with non-targeting scramble siRNA and STAT3 siRNA and cultured under Th17 cell polarizing conditions for
72 hr. The data shown are the mean ± standard error of the mean (SEM) of three cultures. Statistical significance was determined for one sample using two-tailed
Student’s t test (**p < 0.05; ***p < 0.01).
(legend continued on next page)
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RESULTS
STAT3 Is Required for Cytokine-Induced Human Th17
Cell Differentiation
To characterize the role of STAT3 in human Th17 cell differenti-
ation, RNAi was used to downregulate its expression in human
CD4+ T cells (see Figure S1 for information regarding cell purity)
and investigate the effect of this treatment on Th17 cell differen-
tiation. Three different small interfering RNAs (siRNAs) targeting
STAT3 mRNA were used to control reproducibility of the find-
ings. Efficacy of RNAi-mediated knockdown was demonstrated
by decreased expression on STAT3 and its known target, BATF
(Figure 1A). The results showed that the nucleofected cells were
able to polarize as expected indicated by IL-17 secretion (Fig-
ure 1B). Moreover, depletion of STAT3 resulted in decreased
secretion of IL-17 and reduced expression of CCR6, a chemo-
kine receptor highly expressed in Th17 cells (Figures 1B and
1C). These results demonstrate that STAT3 is also an important
regulator of Th17 cell differentiation in human T cells. Thus,
we were able to use these three siRNAs to downregulate
STAT3 expression in order to identify STAT3-regulated genes
(Figure 1D).
Identification of STAT3-Regulated Genes
Gene expression changes in response to Th17 cell polarizing sig-
nals were detected by comparing results on T cells transfected
with non-targeting scramble (Scr) siRNA to those obtained in
cells activated in the absence of Th17 cell polarizing signals
(Th0 cell; Figure 2A). At 2 hr, expression of 2,194 genes was
changed (false discovery rate [FDR] < 0.1). Culturing the cells
for 72 hr in Th17 cell polarizing conditions resulted in changes
in 1,446 genes (Table S1).
To identify STAT3-regulated genes during the early stage of
human Th17 cell differentiation, gene expression profiles from
cells nucleofected with STAT3 siRNAs were compared to pro-
files of cells nucleofected with non-targeting siRNA. Downregu-
lation of STAT3 resulted inmaximal effects in differentiating Th17
cells at the 72-hr time point, where it influenced the expression of
691 genes (Figure 2B). Even at 2 hr, the expression of 157 genes
was reduced in response to STAT3-siRNA, indicating that STAT3
positively regulates the expression of these genes. Conversely,
STAT3 suppresses the expression of 89 genes, including
STAT1, STAT2, and SMAD7 (Figure 2B; Table S1). Throughout
all the time points studied, STAT3 positively and negatively regu-
lated the expression of a similar number of genes (691 versus
576), which is consistent with the idea that STAT3 is important
for both promoting Th17 cell polarization and preventing the abil-
ity of the cells to differentiate to alternative lineages.
To investigate which of the siSTAT3-regulated genes were
changed during the process of Th17 cell differentiation, genes
differentially expressed in Th17 cells (Figure 2A) were overlaid
with siSTAT3-regulated genes (Figure 2B; Table S1). At 2 hr,(C) The percentage of cells expressing CCR6 after 72 hr of polarization. Before in
siRNA. Living cells were gated for the analysis based on FSC and SSC. The d
significance was determined using a two-tailed Student’s t test (**p < 0.05; ***p < 0
the right.
(D) Experimental design for gene expression profiling.
1890 Cell Reports 19, 1888–1901, May 30, 2017siSTAT3 regulated 6.1% of the genes whose expression was
changed in Th17 polarizing cells (Figure 2C). As time of differen-
tiation increased, the proportion of siSTAT3-regulated genes
increased, peaking at 72 hr, where STAT3 was found to regulate
31.6% of the differentially expressed genes (Figure 2C). These
results indicate that STAT3 is an important transcriptional regu-
lator of Th17 cell differentiation.
The expression of NTRK3, IL16, DUSP10, and CASP1 was
found to be regulated by STAT3 at all of the time points studied.
The expression profile of these genes (together with FOSL2,
which is regulated by STAT3 at 12, 24, and 72 hr time points)
was also changed during the Th17 cell differentiation process
(Figure 2D). Expression of 43 genes was changed at least
2.8-fold (signal log ratio [SLR] of 1.5) in response to both Th17
cell differentiating stimuli as well as to STAT3 siRNAs (Figure 2E).
They responded to STAT3 regulation with different dynamics; for
example, GBP4, COL6A3, and CXCR5 responded quickly (at
2 hr) to Th17 cell polarizing stimulation as well as to STAT3
knockdown, whereasCCR6 andCSF2 responded later (at 72 hr).
CXCR5 has been reported to be highly expressed in follicular
helper T (TFH) cells, and both IL-6 and IL-21 induce its expres-
sion in a STAT3-dependent manner (Nurieva et al., 2008). Inter-
estingly, expression of CXCR5 was induced by Th17 cell
polarizing signals, and this induction was reduced at both the
24 hr and 72 hr time points in STAT3-depleted cells, confirming
that CXCR5 is regulated by STAT3 (Figure 2F).
Immediate Target Genes of STAT3
Having identified genes regulated by STAT3 during the early
stages of Th17 cell differentiation, a STAT3 chromatin immuno-
precipitation sequencing (ChIP-seq) study was carried out to
further distinguish the direct and indirect targets of STAT3. To
define an optimal early time point for ChIP-seq, the kinetics of
STAT3 phosphorylation was studied (Figures 3A, S2A, and
S2B). We selected a 0.5 hr time point post-induction of Th17
cell polarization for ChIP-seq, where maximum phospho-
STAT3 was detected in an average of 67% of cells. In total,
2981 STAT3-binding sites were identified (Table S2; Figure S3B),
approximately two-thirds of which were located in introns or
intergenic regions, suggesting that STAT3 may regulate gene
expression via binding to distal regulatory elements (Figure 3B).
Further analysis revealed that 48% of the STAT3 binding sites
were localized within 10 kb up- or down-stream of transcription
start sites (TSS) (Figure 3C). Consistent with the importance of
STAT3 in regulating gene expression via binding to core pro-
moters of its targets, 20% of the binding sites were located in
the immediate promoter region. DNA motif analysis further
confirmed the STAT3 motif as being the strongest motif among
the 2,981 binding sites (p = 10113).
Identification of direct STAT3 target genes was carried out by
combining ChIP-seq results with the list of genes whose expres-
sion was changed during Th17 cell polarization and regulated byduction of polarization, the cells were treated with STAT3-siRNAs or scramble
ata shown on the left are the mean ± SEM of three cultures, and statistical
.01). Representative results from three independent experiments are shown on
(legend on next page)
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STAT3 siRNAs. At 2 hr, 18.8%of the STAT3-regulated and differ-
entially expressed genes in polarizing Th17 cells were found to
be direct targets of STAT3. At later time points, the overlap
was 28.4%and 25.9%at 12 hr and 24 hr, respectively (Figure 3D;
Table S3). To further study how STAT3 binding to TSS and pro-
moter regions influences gene expression dynamics, STAT3-
bound genes at TSS and promoter regions were overlaid with
siSTAT3-regulated differentially expressed genes. Interestingly,
among the siSTAT3-regulated genes, the proportion of STAT3-
bound genes at the TSS-promoter region was similar in all of
the detected time points (Figure S3C; Table S3), even though
STAT3 regulated the expression of many more genes at 72 hr
(Figures 2B and 2C). This suggests that in addition to influencing
gene expression by binding to TSS-promoter regions, STAT3
also influences gene expression by either binding to distal regu-
latory elements or through regulating expression of other tran-
scription factors (TFs). These additional mechanisms amplify
the effect of STAT3 on gene expression as the differentiation
progresses.
In this study, several STATs, including STAT3 itself, were
found to be among the direct STAT3-regulated targets. To
compare the results of this human study with earlier mouse
studies, we overlaid the panel of STAT3-bound genes identified
here and previously published in murine polarizing Th17 cells
(Ciofani et al., 2012; Durant et al., 2010). This revealed that
20% of the STAT3-bound genes identified in this study over-
lapped with those found in the two previous studies, regardless
of the species difference and experimental settings (Figure S4;
Table S4). In addition, our work identified at the 0.5 hr time point
1,211 STAT3-bound genes that were not reported in the other
two studies (Figure S4; Table S4).
To explore whether the dynamic changes in STAT3 phosphor-
ylation (Figure 3A) correlate with the occupancy of STAT3 on its
target genes, STAT3 ChIP was performed at 0, 0.5, 2, 12, and
72 hr after induction of Th17 cell differentiation. To validate re-
sults from ChIP-seq experiments with qPCR, based on the liter-
ature, 15 geneswere selected (Figures S5 and S6); some of these
have been previously reported as STAT3-bound genes, and
others, including MED16, ZNF460, TMEM235, and MALAT1,
are among the 1,211 new STAT3-bound genes in human
T cells identified in this study. To demonstrate the specificity of
STAT3 binding, based on our previous study (Elo et al., 2010),
we selected two STAT6-regulated sites as negative controlsFigure 2. Dynamics of STAT3-Mediated Gene Expression
(A and B) The number of differentially expressed genes (A) and siSTAT3-regulated
independent biological replicates from different donors (FDR < 0.1; see Table S1 f
at a particular time point, with the height of the darker inner part of the bar repre
(C) Proportion of genes regulated by siSTAT3 from all the differentially expressed g
genes).
(D) Heatmap of STAT3-regulated genes throughout the time course. FOSL2 is re
(E) Heatmap of genes that were the most differentially expressed in response to Th
(SLR) between SCR Th17 cell versus Th0 cell >1.5 or <1.5 and between STAT3 s
to these genes in ChIP-seq experiments. Statistically significant changes in gen
dependent biological replicates from different donors (FDR < 0.1).
(F) Expression of CXCR5 is regulated by STAT3. After treating the cells with STA
expression of CXCR5 was detected by flow cytometry at 24 and 72 hr after the in
expressing CXCR5 upon treatment with STAT3-siRNAs or control-siRNA in the ce
from four biological replicates. p values were calculated based using a two-taile
1892 Cell Reports 19, 1888–1901, May 30, 2017and performed ChIP-qPCR detection in three independent cul-
tures (Figure S6B). The results showed that STAT3 bound to
the selected regions of the chosen genes only in cells cultured
for 0.5 hr under Th17 polarizing conditions, confirming the
ChIP-seq results at this time point (Figures 4A and S6A). How-
ever, consistent with the kinetics of STAT3 phosphorylation,
which peaks at 0.5 hr in response to Th17 cell-inducing cyto-
kines, STAT3 binding to these loci was either decreased or not
detected (Figures 4A and S6A). The results indicate that the bind-
ing of STAT3 to its targets changes with time. To further study the
dynamic binding of STAT3, we performed STAT3 ChIP-seq from
cells cultured under Th17 polarizing conditions for 72 hr in three
independent experiments. We identified 4,317 STAT3-bound
sites, 94% of which are located in introns or intergenic regions
andonly 3.6%ofwhich resided in TSSandpromoter regions (Fig-
ure 4B; Table S2). This suggests that at later stages of Th17 dif-
ferentiation, STAT3 influences gene expression mostly through
mechanisms that do not involve direct binding to promoters. To
determine whether STAT3 regulates gene expression by binding
to enhancers, we compared our STAT3 ChIP-seq data obtained
fromboth 0.5 hr and 72 hr to published human Th17 cell enhancer
data (Farh et al., 2015). The results show that 74.8% and 35% of
STAT3 peaks at 0.5 hr and 72 hr, respectively, overlap with the
enhancer mark H3K4me1, suggesting that STAT3 is involved in
shaping enhancers during Th17 differentiation at a very early
stage. Comparing 0.5 hr and 72 hr ChIP-seq data, we found
that STAT3 bound to 213 sites at both time points, representing
203 genes, including STAT3, BATF, TBX21, and SOCS3 (Table
S2). We also overlaid STAT3-bound genes with differentially ex-
pressed genes and siSTAT3-regulated genes during Th17 cell
differentiation. For 16.5% of STAT3-bound genes at 0.5 hr, their
expression was changed after 2 hr of Th17 polarization; at 72 hr,
expression levels of 325 (12%) STAT3-bound genes were
changed, among which 118 genes(36%) were influenced by
siSTAT3, including IL-17F, IL-21, IL-23R, RORA, STAT4,
GATA3, IL-4R, GFI1 (Figure 4C; Table S2). Our study was thus
successful in identifying the very early direct STAT3 targets
involved in the initiation of Th17 cell polarization.
STAT3-Mediated Transcriptional Regulatory Networks
at an Early Stage of Human Th17 Cell Differentiation
Global gene expression profiling and ChIP-seq allowed the iden-
tification of the TFs whose expression was changed during earlygenes (B) during Th17 cell differentiation is shown at each time point from three
or lists of genes). The height of a bar shows the total number of genes detected
senting those genes that were not detected at earlier time points.
enes at each time point during Th17 cell differentiation (see Table S1 for lists of
gulated by STAT3 only at the 12, 24 and 72 hr time points.
17cell differentiation and the most strongly regulated by STAT3 signal log ratio
iRNA versus Scr Th17 cell >1.5 or <1.5). Asterisks indicate that STAT3 bound
e expression in response to STAT3 depletion by RNAi are based on three in-
T3 siRNAs or control siRNA, cells were polarized to Th17 cell phenotype. The
duction of Th17 cell polarization. The Bar chart shows the percentage of cells
lls polarized to Th17 cell direction. Error bars represent SD of the data derived
d Student’s t test (***p < 0.01).
Figure 3. STAT3-Bound Genes
(A) The kinetics of STAT3 phosphorylation during early polarization of Th17 cells. The line chart summarizes the average percentage of phosphorylated STAT3
(pSTAT3)-positive cells at the indicated time points (0–72 hr) in three biological replicates. The error bars show the SD over the replicates. Umbilical cord blood
CD4+ T cells were activated with a-CD3 and a-CD28, with or without the cytokines IL-6, TGF-b, and IL1-b.
(B) The genomic distribution (%) of the identified STAT3-binding sites after 0.5 hr of Th17 cell polarization. STAT3-binding sites were detected by ChIP-seq and
determined by using the MACS tool. See Table S2 for a complete list of STAT3-binding sites.
(C) Distribution of the STAT3 binding sites relative to the position of the closest transcription start site (TSS). TSS is defined to be at position zero in the graph. Out
of all the 2,981 detected binding sites, 1,432 are within ±10 kb from the TSS.
(D) The proportion of STAT3 regulated differentially expressed genes during Th17 cell differentiation that were bound by STAT3 in the ChIP-seq experiment.
These direct STAT3 targets are listed in Table S3.Th17 cell differentiation and directly or indirectly regulated by
STAT3. Maximal changes in the expression of TFs were
observed at 2 hr, where expression of 131 or 113 TFs were
increased or decreased, respectively (Figure 5A). Among them,
29 were regulated by STAT3 (Figure 5B). The expression of
NPAT, ZNF211, andNKAPwas downregulated and their expres-
sion levels increased when STAT3 was downregulated;
conversely, the expression of SMAD7, STAT1, and STAT2 was
upregulated and their expression further enhanced when
STAT3 was downregulated, suggesting that their expression is
repressed by STAT3 (Figure 5C; Table S5). After 2 hr, the number
of differentially expressed TFs was first reduced and then
increased again, and the maximal number of STAT3-regulated
TFs was observed at 72 hr (Figure 5B). A panel of TFs, including
BATF, RORA, FOSL2, IKZF2, IKZF3, HOPX, and AFF3, were
found to be differentially expressed throughout several timepoints (Figure 5D; Table S5), suggesting that these TFs play an
important role in determining the fate of Th17 cell polarization.
The TFs were classified into four groups by integrating the re-
sults. As shown in Figure 5E, the first group, including STAT1,
STAT3, BATF, GATA3, RBPJ, FOSL2, and RORA, contained
direct STAT3 targets, whose expression was changed during
Th17 cell differentiation (Th17 versus Th0 cells) and which were
regulated (STAT3 siRNA versus non-targeting siRNA) and bound
by STAT3 (STAT3 ChIP-seq). The second group contained
indirect STAT3 targets whose expression was changed during
Th17 cell differentiation and that were regulated, but not bound,
by STAT3, suggesting that STAT3 influences their expression
through other factors or mechanisms. This group of genes
contained, for example, ATF3 and ELL2. The third group con-
sisted of putative STAT3 targets differentially expressed during
Th17 cell differentiation that are bound, but not regulated, byCell Reports 19, 1888–1901, May 30, 2017 1893
STAT3. Several TFs previously reported to be involved in differ-
entiation of Th17 or regulatory T cells as well as in TGF-b
signaling were part of this group, including IRF4, NOTCH1,
RUNX3, IKZF4, and JUN (Br€ustle et al., 2007; Fu et al., 2012;
Keerthivasan et al., 2011; Klunker et al., 2009; Li et al., 2012;
Sharma et al., 2013). The fourth group contained TFs differen-
tially expressed in polarizing Th17 cells, but not regulated or
bound by STAT3 (Table S5). This group of genes may act inde-
pendently of STAT3 or interact or cooperate with STAT3 for
Th17 cell lineage specification via the combinatorial transcription
regulation network.
SNPs Associated with Autoimmune Diseases Identified
in STAT3-Binding Sites Alter STAT3 Binding and Are
Enriched among STAT3-Regulated Genes
The essential role of Th17 cells in the pathogenesis of autoim-
mune diseases is well known (Chen and O’Shea, 2008; Korn
et al., 2009). Genome-wide association studies (GWASs) have
identified a large number of disease associated SNPs at different
loci of the genome that can influence the regulation of a gene
several kilobases away from the TSS. We therefore investigated
whether SNPs associated with human diseases are enriched in
regions where STAT3 target genes or STAT3-binding sites
were identified in differentiating Th17 cells in this study. The
STAT3-regulated genes detected at one or more time points
were found to be enriched in many autoimmune diseases,
such as primary biliary cirrhosis (PBC), Behc¸et’s disease, rheu-
matoid arthritis (RA), CD, and ulcerative colitis (UC; Figure S7A).
A list of SNPs with reported associations with 11 different auto-
immune diseases in the GWAS catalog (Hindorff et al., 2009) was
then generated, and their proxies (r2 > 0.8) were calculated
based on the EUR population from the 1000 Genomes Project.
We then extracted the lead SNPs associated with 11 different
autoimmune diseases and their proxies and intersected with
STAT3-binding sites detected early after induction of Th17 cell
differentiation. We found several SNPs to be localized within
STAT3-binding sites (Figure 6A). To test whether STAT3-binding
sites are enriched within each of the autoimmune diseases, we
extracted 1,000 random sets of SNPs using the SNPsnap tool
(see Experimental Procedures) and intersected with STAT3-
binding sites. The enrichment analysis then indicated that
although the individual diseases were not significant after multi-
ple testing correction (Figure 6A), autoimmune-disease-associ-
ated SNPs, when considered as a single trait, overlapped more
often with STAT3-binding sites than a random set of SNPs (p =
0.01, FDR = 0.11).
Next, searching STAT3 motifs shown in Figure 6B, several
SNPs (or their proxies in the Utah residents with northern and
western European ancestry [CEU] or European [EUR] popula-
tion) associated with autoimmune diseases were found (Table 1).
For example, a T1D-associated SNP (rs947474) overlapping
with the STAT3 motif was identified upstream of PFKFB3
(6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 3)
and PRKCQ (protein kinase C, theta). The STAT3 motif was
found in the plus strand, and the mutation was on the 12th nucle-
otide, which was ‘‘strong’’ in the motif, meaning that over 80% of
the bound sequences fromwhich this motif was constructed had
this nucleotide on the same position. In this case, STAT3 was1894 Cell Reports 19, 1888–1901, May 30, 2017predicted to bind to the nonmutated sequence, but not to the
mutated one (Table S6). Furthermore, after searching the blood
expression quantitative trait loci (eQTL) browser (Westra et al.,
2013), STAT3-binding sites were found to overlap with two
SNPs that have a cis eQTL effect (FDR < 0.1). The target
gene of one of them (rs842625) is REL, and the other SNP
(rs947474) has no clear target gene (the probe is located
between LOC399715 and PRKCQ).
A SNP at the STAT3-binding motif could result in either gain or
loss of STAT3 binding. This in turn may alter target gene expres-
sion and Th17 cell differentiation and eventually contribute to
disease. Hence, to examine whether disease-associated SNPs
(or their proxies in the CEUor EURpopulation) at the STAT3motif
could alter STAT3 binding and thereby have a functional effect,
DNA affinity precipitation assays (DAPAs) were carried out
using oligonucleotides containing a STAT3 motif or single base
pair variants (associated SNP) as bait. Six SNPs that overlap
STAT3-binding sites (Tables S7 and 1) were selected. The
DAPA results showed that STAT3 bound to the oligonucleotides
when the reference genome was used; however the binding was
reduced when mutant oligonucleotides corresponding to dis-
ease associated SNPs rs3024505, rs947474, rs6580224, and
rs2293607 were used instead (Figures 6C and S7B). Conversely,
STAT3 binding was increased when mutant oligonucleotide
corresponding to the PS-associated SNP rs12443808 was
used. Mutant oligonucleotide corresponding to PBC-associated
rs17313508 did not alter the STAT3 binding compared with the
reference bait sequence (Figure 6C; Experimental Procedures).
This indicates that introduction of an SNP in the STAT3 motif
alters STAT3 binding and suggests that SNPs may regulate
STAT3 mediated transcription by affecting the expression of tar-
gets that are important for early human Th17 cell differentiation.
DISCUSSION
STAT3 is one of the key TFs needed for Th17 cell differentiation.
The molecular mechanisms by which STAT3 influences down-
stream genes in Th17 cell differentiation have been identified
on a genome-wide level, but only in murine T cells (Ciofani
et al., 2012; Durant et al., 2010). It is therefore essential to
examine in human T cells the targets of STAT3 that may affect
differentiation or function of Th17 cells. Here, we identified the
primary targets of STAT3 that are likely to play important roles
in the initiation of Th17 cell differentiation and orchestrate the
downstream process by influencing other TFs. STAT3 ChIP-
seq at 0.5 hr after Th17 cell stimulation resulted in the mapping
of 2,981 STAT3-binding sites in human T cells at this very early
time point. Moreover, expression of over 1,000 genes was found
to be influenced by STAT3 RNAi. Among the 25 primary STAT3
targets are 4 TFs, including STAT3 itself, suggesting that
STAT3 is able to specify Th17 cell phenotype through a positive
regulatory loop.
Our results show that over half of STAT3 binding sites are
mapped to introns and intergenic regions. By mapping active
enhancer landscapes in differentiated Th1 and Th2 cells, we
(Hawkins et al., 2013) and Vahedi et al. (2012) have shown that
binding of these STAT proteins can activate lineage-specific en-
hancers and suppress enhancers associated with alternative cell
(legend on next page)
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fates (Hawkins et al., 2010, 2013; Vahedi et al., 2012) and regu-
late transcription. It is therefore of interest to find out how STAT3
binding to intergenic regions contributes to epigenetic regulation
or shaping chromatin structures at the early stages of human
Th17 cell differentiation.
Here, we focused on determining the STAT3 targets in pri-
mary human T cells, whereas previous studies have identified
STAT3 targets in murine T cells (Ciofani et al., 2012; Durant
et al., 2010). In order to capture the earliest events to determine
which molecules might be critical for the initiation of Th17 cell
differentiation, ChIP-seq was performed at 0.5 hr and 72 hr in
the present study, whereas in murine T cell studies, the 48 hr
and 72 hr time points were used for STAT3 ChIP-seq experi-
ments. Another difference compared with previous studies is
that in addition to IL-6 and TGF-b1, IL1-b was used in our hu-
man T cell cultures. As a consequence, the signaling pathways
and downstream transcriptional regulatory networks revealed
by the present study differ from those described in the previous
ones. Despite these differences, it was found that among the
2,981 STAT3-binding sites that were mapped to 2,519 anno-
tated genes at 0.5 hr in our study, 1,232 genes (48.9%) were
also bound by STAT3 in murine Th17 polarizing cells at 48 hr,
and 570 genes (22.6%) were also bound by STAT3 in murine
T cells cultured under Th17 cell stimulation for 72 hr and re-
stimulated by IL-6 for 1 hr. Further analysis indicated that
STAT3 bound to 493 genes in all of these three studies (Fig-
ure S2; Table S4). Importantly, 203 genes were already bound
by STAT3 only 0.5 hr after induction of human Th17 cell differ-
entiation (Figure S4). A group of TFs, including BATF, BCL6,
FOSL2, IRF4, IRF9, IKZF1, IKZF4, NOTCH1, RORA, SBNO2,
RBPJ, and STAT3 were among the common genes in which
STAT3 resided both in human and mouse Th17 differentiating
cells. Some of these genes (Table S4), such as IKZF4 and
SBNO2, have not been previously reported to influence Th17
cell differentiation.
To enhance our understanding of the basis of Th7 cell-medi-
ated autoimmune diseases such as RA, T1D, CD, UC, and PS,
we investigated how STAT3-binding sites overlap with SNPs
associated with immune-mediated diseases. Our results sug-
gest that SNPs associated with several autoimmune diseases
co-localize within STAT3-binding sites, and some SNPs local-
ized within STAT3 motifs. An in vitro STAT3-binding assay of a
panel of these STAT3-binding sites indicated that disease-
associated SNPs altered STAT3 binding and hence may
have downstream effects on gene expression. This in turn
may alter Th17 cell differentiation and eventually contribute
to disease. Our study provides insights into the molecular
mechanism of human Th17 cell development and how it can
be regulated, and it provides a basis for understanding andFigure 4. Kinetics of STAT3 Occupancy on Its Target Genes
(A) qPCR results of the selected STAT3 ChIP-seq sites measured at 0, 0.5, 2, 12, a
an average of two to three cultures showing enrichment, with the bars representin
See also Figure S3 for UCSC snapshots.
(B) The genomic distribution (%) of the identified STAT3-binding sites after 72 hr
determined by using the MACS tool. See Table S2 for complete list of STAT3-bin
(C) Overlay of STAT3-bound genes at 72 hr detected byChIP-seqwith differentially
detected by microarrays.
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EXPERIMENTAL PROCEDURES
Human CD4+ T Cell Isolation and Culturing
CD4+ T cells were isolated from umbilical cord blood collected from healthy
neonates born in Turku University Hospital, Hospital District of Southwest
Finland, with approval from the Finnish Ethics Committee. CD4+ T cell isolation
and culture were done as previously described (Tuomela et al., 2012). Detailed
information can be found in Supplemental Experimental Procedures.
STAT3 Knockdown through RNAi
For siRNA-mediated gene silencing, cells were transfected with 5 mg siRNA/
4 3 106 cells targeting STAT3 or a non-targeting control siRNA (Sigma;
sequences are listed in Supplemental Experimental Procedures) using a nucle-
ofector device (Amaxa Biosystems, Lonza), after which cells were rested for
40 hr before culturing.
ForSTAT3 target gene identification, cellswereharvestedat 2, 12, 24,and72hr.
Threebiological replicateswereprepared, each time includingall threedifferent in-
dividual STAT3 siRNAs and non-targeting control siRNA. Total RNA was pro-
cessed and hybridized on Affymetrix GeneChip Human Genome U219 arrays.
STAT3 ChIP-Seq Studies
CD4+ T cells were cultured in Th17 cell polarizing conditions for 0.5 hr and
72 hr. ChIP was performed as previously described (Elo et al., 2010). Cells
were subjected to sonication using a Bioruptor sonicator (Diagenode) to obtain
chromatin fragments of 100–500 bp. 200 mg fragmented chromatin was incu-
bated with 10 mg STAT3 antibody (9132L, Cell Signaling Technology) and incu-
bated for crosslinking with the magnetic beads (no. 112.04 Dynal Biotech, In-
vitrogen). After crosslinking, crosslinks were reversed (65C for 12–16 hr), and
precipitated DNAwas treatedwith Proteinase K and RNase A and then purified
(QIAquick PCR purification kit, QIAGEN). The DNA libraries were prepared by
Fasteris Life Sciences. Sequencing was performed on Illumina HiSeq2000,
producing 18.5–27 million reads per sample.
Kinetic qPCR Analysis of Selected ChIP-Seq Targets
Primers were designed for the representative STAT3-binding regions identified
by the MACS program (Table S7). Two STAT6-binding regions based on our
previous publicationwere selected as negative controls (Elo et al., 2010). Immu-
noprecipitated DNA was analyzed by real-time qPCR (7900HT Fast Real-Time
PCR System, Applied Biosystems) as described earlier (Elo et al., 2010).
DNA Affinity Precipitation Assay
DAPA experiments were conducted as described in our recent study (Hawkins
et al., 2013), with minor modifications. The procedure is described in detail in
Supplemental Experimental Procedures. Oligonucleotides containing STAT3-
binding sites from ChIP-seq data and STAT3 DNA-binding motif, with or
without SNP mutation, were used. Detailed information regarding the se-
quences is presented in Table S7, where mutations introduced to the oligonu-
cleotides are highlighted in bold.
Statistical Methods
Statistical significance of IL17A secretion after 72 hr of culture was determined
from three independent cultures for one sample using a two-tailed Student’s t
test. The statistical significance of the percentage of cells expressing CCR6 ornd 72 hr after induction of Th17 cell polarization. The input value percentage is
g the corresponding SEM. The primers and probes used are listed in Table S7.
of Th17 cell polarization. STAT3-binding sites were detected by ChIP-seq and
ding sites.
expressed genes and siSTAT3 regulated genes during Th17 cell differentiation
(legend on next page)
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Figure 6. SNPs Associated with Autoim-
muneDiseasesOverlap with STAT3 Targets
and Binding Sites
(A) Enrichment of disease-associated SNPs at
STAT3 binding sites relative to random sets of
background SNPs.
(B) Published and de-novo-derived STAT3 DNA-
binding motifs. Known binding motifs were taken
from TRANSFAC (Wingender et al., 2000); de novo
motifs were identified from the STAT3 ChIP-seq
binding sites using Homer software (Heinz et al.,
2010).
(C) DAPA experiments were carried out to assess
whether disease-associated SNPs can alter
STAT3 binding to the binding sites identified with
STAT3 ChIP-seq. Double-stranded oligonucleo-
tides containing the predicted STAT3-binding
sites at different genomic locations were used as
baits. STAT3 binding to the oligonucleotide bait
sequences was examined using nuclear extracts
from polarized Th17 cells at the 48 hr time point.
The oligonucleotide baits containing the SNPs at
STAT3-binding sites are shown in Table S7. A
DNA sequence with a STAT3-binding site (STAT3
WT) and a negative control DNA sequence (STAT3
MT and an oligonucleotide where 4 nt of the
conserved STAT3-binding site has been mutated)
were used as controls. STAT3 binding to oligo-
nucleotides was detected by western blotting
using STAT3-specific antibodies. Data are repre-
sentative of two biological replicates (Figure S7B).CXCR5 after 72 hr of polarization was determined using a two-tailed Student’s
t test. Statistical analysis for microarray, ChIP-seq, and SNPs in association
with STAT3-binding sites is described below.
Identification of STAT3 Targets
Affymetrix microarray data were processed using the robust multi-array
average (RMA) algorithm (Irizarry et al., 2003), quantile normalized (Bio-
conductor Affy package v.1.52), and log2 transformed. Th17 cell-specificFigure 5. STAT3-Mediated Dynamic Transcription Network
(A and B) Bar charts showing total numbers of (A) differentially expressed TFs and (B) STAT3 regulated TFs d
height of a bar shows the total number of differentially expressed genes detected at a particular time point. The
whose differential expression was already detected earlier, whereas the height of the darker outer part represe
detected for the first time at a given time point. The expression profiles of these transcriptional regulators ar
(C and D) Heatmaps of STAT3-regulated TFs at 2 hr (C) or 72 hr (D). STAT3-regulated TFs were identified
nucleofected by STAT3 siRNA versus Scr, cultured under Th17 cell polarizing conditions (FDR < 0.1). Statist
pendent experiments. Statistically significantly changed signal log ratios (SLRs) are shown. The asterisks on
genes by ChIP-seq experiment in this study.
(E) STAT3-dependent and independent transcription circuitries. STAT3-dependent genes were chosen base
kines, when compared to the Th0 cell sample (FDR < 0.1), regulation by STAT3 siRNA (FDR < 0.1), or by detect
induced by Th17 polarizing cytokines and regulated by direct DNA binding as well as in STAT3 RNAi exp
regulated by STAT3 siRNA, but not bound by STAT3. Putative STAT3 target genes were regulated by Th17 cel
and were bound by STAT3 in ChIP-seq experiments but were not regulated by STAT3 in the RNAi experiments
regulated by STAT3-specific siRNA, they were regulated by Th17 cell polarizing cytokines in the control-siR
genes were also expressed differentially when compared between Th17 and Th0 cell sample. The expression o
24, and 72 hr are represented as bar charts next to the nodes.
1898 Cell Reports 19, 1888–1901, May 30, 2017genes were identified between the matched
Th17 cell and Th0 cell measurements (same time
point and culture) in the control-siRNA data using
paired and moderated t-statistic (Bioconductor
limma package v.3.30.4) by using the batch as a
covariate. Genes with an FDR < 0.1 were definedas ‘‘changed’’ for each time point (Benjamini, 1995). The effect of STAT3
knockdown on gene expression was assessed using the Th17 cell measure-
ments from the matched STAT3 siRNA and control siRNA samples using the
analysis methods described above.
STAT3 ChIP-Seq Data Analysis
The 50-nt reads were aligned to the human reference genome (hg19) using
Bowtie software (Langmead et al., 2009). Only uniquely mapped reads wereuring the early stage of Th17 cell polarization. The
height of the lighter inner part represents those TFs
nts those TFs whose differential expression is now
e listed in Table S5.
by comparing gene expression profiles from cells
ical analysis was performed based on three inde-
gene names indicate that STAT3 bound to these
d on their regulation by Th17 cell polarizing cyto-
ed STAT3 binding. STAT3 direct target genes were
eriments. Importantly, STAT3 indirect targets are
l polarizing cytokines in the kinetic data (FDR < 0.1)
. Although the STAT3-independent genes were not
NA experiments (FDR < 0.1). STAT3-independent
f Th17 cell-regulated genes (FDR < 0.1) from 2, 12,








SNP Position at STAT3
Motif (strand/nt) STAT3 Motif Sequence Logoa
Nearest
Gene(s) Gene Functionb
rs3024505 1 206939904 C-C/T CD, T1D, UC +/8*, m+/8* IL10 IL10 is an immunoregulatory cytokine with
pleotropic functions. It plays a key role in the
control of Th1, and pathogenic function of Th17
cell.
rs947474 10 6390450 G+A/G T1D +/12*, –/10* PFKFB3,
LOC399715,
PRKCQ
PFKFB3 is required for the stimulation of glycolysis
in T cells and T helper cell differentiation. PRKCQ
enhances Th17 differentiation in a STAT3-
dependent manner.
rs17313508 5 35953949 G+A/G PBC m+/14*, m–/8* IL7R,
CAPSL,
UGT3A1
IL-7R is involved in long-term survival of T cells
and has been associated with several
inflammatory autoimmune diseases as well in
cancer. The CASPL gene is located in IL-7R loci,
and its function is unknown. UGT3A1 may play an
important role in metabolism, and its role in the
context of the immune system is understudied.
rs6580224 5 141489306 A+A/G MS +/14*, –/8* NDFIP1,
GNPDA1,
SPRY4
NDFIP1 is induced by TGF-b to induce iTreg
differentiation and limit Th2 and Th17
differentiation.
The function of GNPDA1 is unknown. SPRY4 is
inhibits the receptor-transduced mitogen-
activated protein kinase (MAPK) signaling
pathway.
rs12443808 16 30996871 C+C/G PS m+/6* SETD1A,
HSD3B7,
STX1B
SETD1A is histone methylatransferase that
specifically methylates Lys 4 residue of H3. Thus, it
plays a key role in chromatin organization and
gene regulation. HSD3B7 is an enzyme with a role
in the biosynthesis of bile acid. STX1B has a role in
synaptic transmission and has been implicated in
several neurologic diseases.
rs2293607 3 169482335 T-A/G CeD, MS +/6, m+/6 TERC,
ACTRT3
TERC is a telomerase RNA component associated
with colitis and malignancies. ACTRT3 is a gene of
unknown function
Several SNPs (or their proxies in CEU or EUR population) associated with autoimmune diseases overlapping with STAT3 motifs were selected. References for gene function are given in
Supplemental Information. CeD, celiac disease.
aThe STAT3 motif sequence logo derived from TRANSFAC motifs: V$STAT3_Q1 and V$STAT3STAT3_Q3.



































retained (16–23 million reads per sample). STAT3-binding sites in Th17 cells
relative to input DNA were identified using the MACS tool (Zhang et al., 2008)
with default parameter settings. To obtain a consensus set of peaks from repli-
cate experiments, peaks were called for each individual dataset using MACS2
(https://github.com/taoliu/MACS/) and then combined using irreproducible
discovery rate (IDR) (Li et al., 2011) following instructions on https://sites.
google.com/site/anshulkundaje/projects/idr and selecting the conservative
peak set. De novomotifs from the STAT3 ChIP-seq peaks were detected using
Homer software (Heinz et al., 2010). The binding sites were annotated in terms
of genomic annotations using the ‘‘annotatePeaks.pl’’ script supplied by
Homer. For overlapping features, the following priorities were applied: (1)
TSS (TSS 1 kb, TSS + 100 bp), (2) TTS (TTS 100 bp, TSS + 1kb), (3) coding
DNA sequence (CDS) exons, (4) 50 UTR exons, (5) 30 UTR exons, (6) introns,
and (7) intergenic.
SNP Enrichment Analysis
All GWAS SNPs from 11 autoimmune diseases were extracted from the Na-
tional Human Genome Research Institute (NHGRI) GWAS catalog as per
January 2013 (Hindorff et al., 2009). SNPs associatedwith thewhite population
were selected, and SNPs associated by meta-analysis of two diseases were
excluded. Proxies within a distance limit of 500 kb and with r2 > 0.8 were iden-
tified based on the CEU population from the 1000 Genomes Project using
SNAP (Johnson et al., 2008) (Figure 6A; Table S6) and then searched for
STAT3-binding sites containing these SNPs.
In order to test if there is enrichment of STAT3 sites, all traits were analyzed
separately. We first excluded the lead SNPs located in the HLA region (chro-
mosome 6, 25–35 Mb). If any SNPs were correlated (physical distance =
1,000 kb and LD r2 = 0.8), we kept only one of the correlated SNPs. We then
used SNPsnap (Pers et al., 2015) with the default parameters (except physical
distance = 1,000 kb and LD buddies ±20% with r2 = 0.8) to randomly sample
1,000 SNP sets with the same size as the original filtered SNP set. For both dis-
ease and background lead SNPs, proxies were generated from the 1000 Ge-
nomes EUR population biallelic variants using plink 1.9 (Chang et al., 2015) by
selecting SNPs in 1,000-kbp window with r2 = 0.8. The extended proxy SNPs
(including the lead SNPs) were intersected with the STAT3 sites. p values were
calculated based on these empirical background distributions and corrected
for multiple testing using the Benjamini-Hochberg method (Benjamini, 1995).
To study enrichments with a larger set of diseases, genes were associated
with a disease if an SNP associated with the disease as reported in the NHGRI
GWAS catalog was within ±100 kbp of the gene. The focus was on genes that
were regulated by STAT3 (absolute log2 fold-change >1.2 in at least one time
point) during Th17 cell differentiation. Only diseases with more than one asso-
ciated gene were included. Enrichment of diseases among STAT3 regulated
genes were obtained by the binomial test and p values were corrected for mul-
tiple testing using the Benjamini-Hochberg method.
STAT3 motif locations within ChIP-seq peaks were detected by motif scan-
ning using a uniform 0th order background model and p value threshold of
0.001 (estimated by sampling 10,000 random sequences from the genome
with a length equal to the mean of STAT3-binding site lengths). If more than
one peak was found, the strongest peak was selected.
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